Authors: Richard D. Gelber, Marco Colleoni, Beat Thürlimann, C. Kent Osborne, Masakazu Toi, Kathleen I. Pritchard, A S Coates, James N. Ingle, Per Karlsson, Paul E. Goss, Andrew Tutt, Zefei Jiang, Denisse Bretel-Morales, E P Winer, Toru Watanabe, Sibylle Loibl, Pamela J. Goodwin, Giuseppe Viale, Angelo Di Leo, Vladimir Semiglazov, Bent Ejlertsen, B. Thürlimann, Felix Sedlmayer, Jacek Jassem, Frédérique Penault-Llorca, R. D. Gelber, Daniel F. Hayes, Eric P. Winer, Aron Goldhirsch, Giuseppe Curigliano, Ian E. Smith, A. Goldhirsch, Martine Piccart-Gebhart, Monica Morrow, Fatima Cardoso, Alberto Costa, Nancy E. Davidson, Kathy S. Albain, Hervé Bonnefoi, Harold J. Burstein, Emiel J. Th. Rutgers, Clifford A. Hudis, John F. Forbes, H.-J. Senn, Jonas Bergh, Michael Gnant, Nicholas Wilcken, Fabrice Andre, William C. Wood, Michael Untch, Moïse Namer, Charles M. Perou, Ann H. Partridge, Z Shao, M. Castiglione-Gertsch, Jay R. Harris, Alan S. Coates, M Piccart-Gebhart
Source:
Annals of Oncology
Annals of oncology, 24 (9
Subject Terms: Special Article, surgery, radiation therapy, systemic adjuvant therapies, early breast cancer, St Gallen Consensus, subtypes, Sciences bio-médicales et agricoles, Breast Neoplasms -- drug therapy -- surgery -- therapy, Chemotherapy, Adjuvant, Combined Modality Therapy, Early Detection of Cancer, Female, Humans, Individualized Medicine -- methods, Mastectomy, Receptor, ErbB-2 -- antagonists & inhibitors -- metabolism, Oncology, Hematology, Chemotherapy regimen, Medicine, business.industry, business, Surgery, medicine.medical_specialty, Adjuvant therapy, Radiation therapy, medicine.medical_treatment, Intensive care medicine, Breast cancer, medicine.disease, Disease, Personalized medicine, Trastuzumab, medicine.drug, Precision medicine
File Description: 2 full-text file(s): application/pdf; application/pdf
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf6ae63884adf1a92f91b7fe130514e
http://europepmc.org/articles/PMC3755334
Authors: Hilda Wong, Raymond Liang, Charles Swanton, R. Leung, Ava Kwong, Joanne Chiu, Thomas Yau
Subject Terms: AKT, PI3 kinase, Trastuzumab, Breast cancer, mTOR, ErbB-2, Humans, Receptor, Erbb-2 - Antagonists & Inhibitors - Biosynthesis - Genetics - Metabolism, Prospective Studies, Neoplasm Metastasis, Female, Drug Resistance, Neoplasm, Breast Neoplasms - Drug Therapy - Enzymology - Genetics - Pathology, Antineoplastic Agents - Pharmacology, Antibodies, Monoclonal, Humanized - Pharmacology, skin and connective tissue diseases, Cancer Research, Oncology, Cancer, medicine.disease, medicine, Internal medicine, medicine.medical_specialty, Clinical trial, Epidermal growth factor receptor, biology.protein, biology, Immunology, business.industry, business, Disease Response, Drug resistance, medicine.drug, Metastatic breast cancer, neoplasms
Access URL:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aadf4dece0fdb7e044dc64d3c6d00726
http://hdl.handle.net/10722/163425
Authors: Cirstoiu, Adriana, Buchegger, Franz, Bossy, Leila, Kosinski, M, Gurny, Robert, Delie Salmon, Florence
Source: European Journal of Pharmaceutical Sciences, Vol. 38, No 3 (2009) pp. 230-237
Subject Terms: ddc:615, ddc:616.0757, Antibodies/administration & dosage/*chemistry/metabolism, Binding Sites, Antibody, Cell Line, Tumor, Drug Carriers/administration & dosage/chemistry, Drug Delivery Systems/*methods, Humans, Nanomedicine/*methods, Nanoparticles/administration & dosage/*chemistry, Paclitaxel/administration & dosage/*chemistry, Physicochemical Phenomena, Receptor, erbB-2/*antagonists & inhibitors/*immunology/metabolism, technology, industry, and agriculture
Access URL:
https://explore.openaire.eu/search/publication?articleId=od______1400::a862f5c1a8fd771fbdc644307edbc7aa
https://archive-ouverte.unige.ch/unige:19744
Source: Annals of oncology, 29 (8
Index Terms: Sciences bio-médicales et agricoles, Adult, Aged, Antineoplastic Agents, Immunological -- administration & dosage -- adverse effects, Breast -- pathology -- surgery, Breast Neoplasms -- blood -- mortality -- therapy, Cardiotoxicity -- epidemiology -- etiology, Chemotherapy, Adjuvant -- methods, Disease-Free Survival, Female, Humans, Mastectomy, Middle Aged, Neoplastic Cells, Circulating -- drug effects, Receptor, ErbB-2 -- antagonists & inhibitors -- metabolism, Trastuzumab -- administration & dosage -- adverse effects, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Cancer treatment reviews, 57
Index Terms: Cancérologie, Imagerie médicale, radiologie, tomographie, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Breast Neoplasms -- drug therapy -- enzymology -- immunology -- pathology, Chemotherapy, Adjuvant, Female, Humans, Lapatinib, Lymphocytes, Tumor-Infiltrating -- drug effects -- immunology -- pathology, Neoadjuvant Therapy, Quinazolines -- administration & dosage, Randomized Controlled Trials as Topic, Receptor, ErbB-2 -- antagonists & inhibitors -- biosynthesis, Trastuzumab -- administration & dosage, HER2-postive breast cancer, Neoadjuvant treatment, Pathologic complete response, Trastuzumab, Tumor-infiltrating lymphocytes, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Journal of clinical oncology, 32 (29
Index Terms: Cancérologie, Médecine pathologie humaine, Sciences bio-médicales et agricoles, Adult, Aged, Anthracyclines -- administration & dosage, Antibodies, Monoclonal, Humanized -- administration & dosage, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Breast Neoplasms -- drug therapy -- genetics -- pathology, Exons, Female, Genotype, Humans, Middle Aged, Mutation, Neoadjuvant Therapy, Phosphatidylinositol 3-Kinases -- genetics, Quinazolines -- administration & dosage, Randomized Controlled Trials as Topic, Receptor, ErbB-2 -- antagonists & inhibitors -- genetics, Taxoids -- administration & dosage, Treatment Outcome, Tumor Markers, Biological -- analysis, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Journal of clinical oncology, 32 (29
Index Terms: Cancérologie, Médecine pathologie humaine, Sciences bio-médicales et agricoles, Adult, Aged, Anthracyclines -- administration & dosage, Antibodies, Monoclonal, Humanized -- administration & dosage, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Breast Neoplasms -- drug therapy -- genetics -- pathology, Exons, Female, Genotype, Humans, Middle Aged, Mutation, Neoadjuvant Therapy, Phosphatidylinositol 3-Kinases -- genetics, Quinazolines -- administration & dosage, Randomized Controlled Trials as Topic, Receptor, ErbB-2 -- antagonists & inhibitors -- genetics, Taxoids -- administration & dosage, Treatment Outcome, Tumor Markers, Biological -- analysis, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Annals of oncology, 24 (9
Index Terms: Sciences bio-médicales et agricoles, Breast Neoplasms -- drug therapy -- surgery -- therapy, Chemotherapy, Adjuvant, Combined Modality Therapy, Early Detection of Cancer, Female, Humans, Individualized Medicine -- methods, Mastectomy, Receptor, ErbB-2 -- antagonists & inhibitors -- metabolism, St Gallen Consensus, early breast cancer, radiation therapy, subtypes, surgery, systemic adjuvant therapies, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Cancer research, 73 (19
Index Terms: Cancérologie, Antibodies, Monoclonal, Humanized -- economics -- therapeutic use, Antineoplastic Agents -- economics -- therapeutic use, Breast Neoplasms -- drug therapy -- economics -- metabolism, Drug Delivery Systems, Female, Humans, Molecular Targeted Therapy -- economics, Receptor, ErbB-2 -- antagonists & inhibitors -- immunology, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Annals of oncology, 24 (9
Index Terms: Sciences bio-médicales et agricoles, Breast Neoplasms -- drug therapy -- surgery -- therapy, Chemotherapy, Adjuvant, Combined Modality Therapy, Early Detection of Cancer, Female, Humans, Individualized Medicine -- methods, Mastectomy, Receptor, ErbB-2 -- antagonists & inhibitors -- metabolism, St Gallen Consensus, early breast cancer, radiation therapy, subtypes, surgery, systemic adjuvant therapies, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Cancer research, 73 (19
Index Terms: Cancérologie, Antibodies, Monoclonal, Humanized -- economics -- therapeutic use, Antineoplastic Agents -- economics -- therapeutic use, Breast Neoplasms -- drug therapy -- economics -- metabolism, Drug Delivery Systems, Female, Humans, Molecular Targeted Therapy -- economics, Receptor, ErbB-2 -- antagonists & inhibitors -- immunology, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Current opinion in oncology, 24 (6
Index Terms: Cancérologie, Antibodies, Monoclonal, Humanized -- administration & dosage, Antineoplastic Combined Chemotherapy Protocols -- pharmacology -- therapeutic use, Breast Neoplasms -- drug therapy -- metabolism, Clinical Trials as Topic, Female, Humans, Molecular Targeted Therapy, Neoplasms, Hormone-Dependent -- drug therapy -- metabolism, Quinazolines -- administration & dosage, Quinolines -- administration & dosage, Receptor, erbB-2 -- antagonists & inhibitors -- metabolism, Signal Transduction, breast cancer, dual antihuman epidermal growth factor receptor 2 blockade, human epidermal growth factor receptor 2, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Current opinion in oncology, 24 (6
Index Terms: Cancérologie, Antibodies, Monoclonal, Humanized -- administration & dosage, Antineoplastic Combined Chemotherapy Protocols -- pharmacology -- therapeutic use, Breast Neoplasms -- drug therapy -- metabolism, Clinical Trials as Topic, Female, Humans, Molecular Targeted Therapy, Neoplasms, Hormone-Dependent -- drug therapy -- metabolism, Quinazolines -- administration & dosage, Quinolines -- administration & dosage, Receptor, erbB-2 -- antagonists & inhibitors -- metabolism, Signal Transduction, breast cancer, dual antihuman epidermal growth factor receptor 2 blockade, human epidermal growth factor receptor 2, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Current opinion in oncology, 23 (6
Index Terms: Cancérologie, Animals, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Breast Neoplasms -- drug therapy -- enzymology, Female, Humans, Mammary Neoplasms, Experimental -- drug therapy -- enzymology, Molecular Targeted Therapy, Protein Kinase Inhibitors -- administration & dosage, Receptor, erbB-2 -- antagonists & inhibitors -- biosynthesis, breast cancer, human epidermal growth factor 2 (HER2), neoadjuvant, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Current opinion in oncology, 23 (6
Index Terms: Cancérologie, Animals, Antineoplastic Combined Chemotherapy Protocols -- therapeutic use, Breast Neoplasms -- drug therapy -- enzymology, Female, Humans, Mammary Neoplasms, Experimental -- drug therapy -- enzymology, Molecular Targeted Therapy, Protein Kinase Inhibitors -- administration & dosage, Receptor, erbB-2 -- antagonists & inhibitors -- biosynthesis, breast cancer, human epidermal growth factor 2 (HER2), neoadjuvant, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Expert review of anticancer therapy, 10 (8
Index Terms: Cancérologie, Animals, Antineoplastic Agents, Hormonal -- administration & dosage -- metabolism, Breast Neoplasms -- drug therapy -- metabolism, Drug Delivery Systems -- methods, Drug Resistance, Neoplasm, Female, Humans, Receptor Cross-Talk -- drug effects -- physiology, Receptor, erbB-2 -- antagonists & inhibitors -- metabolism, Receptors, Estrogen -- antagonists & inhibitors -- metabolism, aromatase inhibitors, cross-talk, estrogen receptor, HER2, lapatinib, resistance, trastuzumab, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Expert opinion on investigational drugs, 19 Suppl 1
Index Terms: Cancérologie, Antibodies, Monoclonal -- administration & dosage, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics -- therapeutic use, Breast Neoplasms -- drug therapy -- pathology, Chemotherapy, Adjuvant -- methods, Disease Progression, Drug Delivery Systems, Drug Resistance, Neoplasm, Female, Humans, Neoplasm Metastasis, Receptor, erbB-2 -- antagonists & inhibitors -- metabolism, Signal Transduction -- drug effects, Adjuvant therapy, Chemotherapy, Human epidermal growth factor receptor-2 (HER2), Metastatic breast cancer, Trastuzumab, Tyrosine kinase inhibitors, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Expert review of anticancer therapy, 10 (8
Index Terms: Cancérologie, Animals, Antineoplastic Agents, Hormonal -- administration & dosage -- metabolism, Breast Neoplasms -- drug therapy -- metabolism, Drug Delivery Systems -- methods, Drug Resistance, Neoplasm, Female, Humans, Receptor Cross-Talk -- drug effects -- physiology, Receptor, erbB-2 -- antagonists & inhibitors -- metabolism, Receptors, Estrogen -- antagonists & inhibitors -- metabolism, aromatase inhibitors, cross-talk, estrogen receptor, HER2, lapatinib, resistance, trastuzumab, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Expert opinion on investigational drugs, 19 Suppl 1
Index Terms: Cancérologie, Antibodies, Monoclonal -- administration & dosage, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics -- therapeutic use, Breast Neoplasms -- drug therapy -- pathology, Chemotherapy, Adjuvant -- methods, Disease Progression, Drug Delivery Systems, Drug Resistance, Neoplasm, Female, Humans, Neoplasm Metastasis, Receptor, erbB-2 -- antagonists & inhibitors -- metabolism, Signal Transduction -- drug effects, Adjuvant therapy, Chemotherapy, Human epidermal growth factor receptor-2 (HER2), Metastatic breast cancer, Trastuzumab, Tyrosine kinase inhibitors, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL:
Source: Clinical cancer research, 15 (6
Index Terms: Cancérologie, Médecine pathologie humaine, Sciences bio-médicales et agricoles, Antibodies, Monoclonal -- adverse effects, Antibodies, Monoclonal -- therapeutic use, Breast Neoplasms -- chemistry, Breast Neoplasms -- drug therapy, Female, Humans, Receptor, erbB-2 -- analysis, Receptor, erbB-2 -- antagonists & inhibitors, Receptor, erbB-2 -- physiology, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article
URL: